Commercializing the first wearable device to deliver a safe, effective, non-invasive treatment for cognitive decline caused by neurodegenerative diseases like Alzheimer’s (AD) and aging. Backed by multiple patents, our technology showed cognitive improvement in 7 out of 8 AD sufferers in peer-reviewed human clinical studies. With FDA Breakthrough Device Designation, we are pioneering the transformation of brain health and neurodegenerative care.